AMBU B Stock Overview
A medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Innovative aScope 5 Uretero And Sustainable Initiatives Will Accelerate Revenue Growth
My Notes
Capture your thoughts, links and company narrative
Ambu A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 141.65 |
| 52 Week High | DKK 154.60 |
| 52 Week Low | DKK 103.70 |
| Beta | 0.91 |
| 1 Month Change | 4.69% |
| 3 Month Change | 24.31% |
| 1 Year Change | 12.73% |
| 3 Year Change | 30.79% |
| 5 Year Change | -7.69% |
| Change since IPO | 8,171.54% |
Recent News & Updates
Earnings Miss: Ambu A/S Missed EPS By 6.2% And Analysts Are Revising Their Forecasts
Feb 02
Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends
Jan 27Revenues Tell The Story For Ambu A/S (CPH:AMBU B) As Its Stock Soars 27%
Jan 12Recent updates
Earnings Miss: Ambu A/S Missed EPS By 6.2% And Analysts Are Revising Their Forecasts
Feb 02Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends
Jan 27Revenues Tell The Story For Ambu A/S (CPH:AMBU B) As Its Stock Soars 27%
Jan 12Is It Too Late To Consider Buying Ambu A/S (CPH:AMBU B)?
Dec 31Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year
Nov 28Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality
Nov 13Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts
Nov 07Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next
Sep 02Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital
Aug 06Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity
Apr 06Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)
Mar 14Shareholder Returns
| AMBU B | DK Medical Equipment | DK Market | |
|---|---|---|---|
| 7D | 5.1% | 0.5% | 2.9% |
| 1Y | 12.7% | -12.8% | -17.7% |
Return vs Industry: AMBU B exceeded the Danish Medical Equipment industry which returned -10.6% over the past year.
Return vs Market: AMBU B exceeded the Danish Market which returned -17.5% over the past year.
Price Volatility
| AMBU B volatility | |
|---|---|
| AMBU B Average Weekly Movement | 6.0% |
| Medical Equipment Industry Average Movement | 4.2% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DK Market | 9.6% |
| 10% least volatile stocks in DK Market | 2.7% |
Stable Share Price: AMBU B has not had significant price volatility in the past 3 months compared to the Danish market.
Volatility Over Time: AMBU B's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 5,000 | Britt Jensen | www.ambu.com |
Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Ambu A/S Fundamentals Summary
| AMBU B fundamental statistics | |
|---|---|
| Market cap | DKK 37.73b |
| Earnings (TTM) | DKK 326.00m |
| Revenue (TTM) | DKK 5.65b |
115.7x
P/E Ratio6.7x
P/S RatioIs AMBU B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMBU B income statement (TTM) | |
|---|---|
| Revenue | DKK 5.65b |
| Cost of Revenue | DKK 2.26b |
| Gross Profit | DKK 3.39b |
| Other Expenses | DKK 3.06b |
| Earnings | DKK 326.00m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 07, 2025
| Earnings per share (EPS) | 1.22 |
| Gross Margin | 59.98% |
| Net Profit Margin | 5.77% |
| Debt/Equity Ratio | 0% |
How did AMBU B perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield31%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/20 04:45 |
| End of Day Share Price | 2025/02/20 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ambu A/S is covered by 17 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Michael Healy | Berenberg |
| Alexander Berglund | BofA Global Research |